3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Sleep Apnea Syndromes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisensehr, I; Gildehaus, JF; Kharraz, B; Linke, R; Noachtar, S; Schwarz, J; Tatsch, K; Trenkwalder, C; Wetter, CT | 1 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Sleep Apnea Syndromes
| Article | Year |
|---|---|
Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease
Topics: Adult; Aged; Apnea; Benzamides; Caudate Nucleus; Contrast Media; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Electromyography; Eye Movements; Female; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Oculomotor Muscles; Polysomnography; Prospective Studies; Putamen; Pyrrolidines; Receptors, Presynaptic; REM Sleep Behavior Disorder; Sleep Apnea Syndromes; Time Factors; Tomography, Emission-Computed, Single-Photon | 2003 |